Conversely, the relationship between boost dose to lymph node metastases and OS did not reach statistical significance in either univariate or multivariate analysis.
← all excerpts
Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG).
1
—
—